Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Pfizer Inc PFE

Alternate Symbol(s):  N.PFE

Healthcare
Pfizer Inc. is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment is engaged in the science-based biopharmaceutical business. Its Biopharma segment includes the Pfizer Oncology Division, the Pfizer U.S. Commercial Division, and the... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NYSE:PFE)

Pfizer Reports First-Quarter 2024 Results

Business Wire 3 days ago

FDA Grants Full Approval for TIVDAK® to Treat Recurrent or Metastatic Cervical Cancer

Business Wire 5 days ago

TIVDAK® (tisotumab vedotin-tftv) Receives U.S. FDA Approval to Treat Recurrent or Metastatic Cervical Cancer

Business Wire 5 days ago

Pfizer Highlights Progress in Accelerating Breakthrough Cancer Medicines at ASCO 2024 Annual Meeting

Business Wire 5 days ago

U.S. FDA Approves Pfizer's BEQVEZ(TM) (fidanacogene elaparvovec-dzkt), a One-Time Gene Therapy for Adults with Hemophilia B

Business Wire 8 days ago

Pfizer Declares Second-Quarter 2024 Dividend

Business Wire 10 days ago

European Commission Approves Pfizer's EMBLAVEO® for Patients with Multidrug-Resistant Infections and Limited Treatment Options

Business Wire 12 days ago

Pfizer Invites Shareholders to Attend Virtual-Only 2024 Annual Meeting of Shareholders on April 25

Business Wire April 11, 2024

Pfizer Announces Positive Top-Line Results from Phase 3 Study of ABRYSVO® in Adults Aged 18 to 59 at Increased Risk for RSV Disease

Business Wire April 9, 2024
View More News ››

Opinion & Analysis (NYSE:PFE)

BioNTech, Eastman Kodak, EXMceuticals - investors have the chance to profit

Stockhouse Editorial July 29, 2020

BioNTech, Evotec, EXMceuticals - which stocks have the potential to double?

Stockhouse Editorial June 18, 2020

Buzz on the Bullboards: HOT Coronavirus Healthcare Stocks

Omri Wallach March 19, 2020

Mylan Gets a Shot in the Arm with Pfizer Merger Deal

Streetwise Reports July 31, 2019

Sangamo and Pfizer Report Positive Results for Hemophilia A Study

Streetwise Reports July 9, 2019

The ProMIS of an Alzheimer's cure

The Life Sciences Report May 4, 2017
View More Opinion ››

Bullboard Posts (NYSE:PFE)

Stock price Moving average

Here are the stats. We are slowly but surely walking toward the 200 MDA.  Period Moving Average Price...
ecolo101 - 1 day ago

Q1 results beat expectations

PFE  Pfizer Inc.  Q1  $0.82  Beat by $0...
ecolo101 - 2 days ago

Trading volume today

We are way higher than the average 42 millions shares per day we are at 55 million and keep increasing. this is very good with a 6% stock...
ecolo101 - 3 days ago

Excellent Quarterly report

And here we go, up up and probably up...  and ex dividend date coming soon. glta dyodd
ecolo101 - 3 days ago

1998 value , $25

Difficult to understand and on top maximum inflation lately. So if you put it in constant dollar, this is a disaster. Bagholders are...
ecolo101 - 4 days ago

Let’s hope for a W shape

Starting right now.... Pfizer should do way better than this on stock price. We should be around $30 by now... dyodd
ecolo101 - 5 days ago
View more Bullboard ››

Sandstorm Gold Ltd.

Sandstorm Gold Ltd.

Sandstorm Gold Ltd. is a Canada-based precious metals-focused streaming and royalty company. The Company is focused on ...
View More »